How Long Are You Contagious With COVID-19: Day by Day

Most people with COVID-19 are contagious for roughly five to ten days after symptoms start, with the highest risk of spreading the virus concentrated in the first few days of illness. The exact timeline depends on your immune status, which variant you caught, and whether you’ve been vaccinated, but the general arc is consistent: viral shedding ramps up fast, peaks early, and then gradually declines. What makes this tricky is that contagiousness doesn’t map neatly onto how you feel, and a positive PCR test can linger long after you’ve stopped being able to infect anyone.

Contagiousness Starts Before You Feel Sick

One of the most consequential features of SARS-CoV-2 is that you become contagious before you know you’re infected. The virus begins replicating in your upper respiratory tract during the incubation period, and by the time symptoms appear, you’ve likely already been shedding enough virus to infect others. Estimates of how much transmission happens before symptom onset vary, but research using contact-tracing data from Singapore and Tianjin, China found that pre-symptomatic transmission accounted for roughly 40 to 75 percent of all transmission events, depending on the assumptions used in the analysis.¹

With Omicron subvariants, the gap between exposure and viral shedding has shortened compared to earlier strains. For the Delta variant, the average latent period was about 4.4 days, meaning people started shedding virus roughly four and a half days after exposure. For the BA.1 and BA.2 Omicron sublineages, that dropped to about 2.5 days.² The latent period was also consistently shorter than the incubation period by about a day, which means you’re shedding virus roughly a day before your first sniffle or sore throat. This is why COVID-19 has been so hard to contain through symptom-based screening alone.

The Day-by-Day Arc of Contagiousness

Researchers track contagiousness by measuring viral load (how much virus is in your respiratory samples) and viral culture (whether the virus in those samples can actually infect cells in a lab dish). Culture positivity is the gold standard for determining whether you’re likely to transmit, because it tells you the virus is still alive and capable of replicating. Here’s what the evidence shows, anchored to the day symptoms begin:

Day 0 (symptom onset): You’re already contagious and have been for roughly a day or two. Viral load is rising rapidly but hasn’t peaked yet.
Days 1 through 4: This is the steepest part of the curve. Viral loads climb and typically reach their peak around day 3 to 4 after symptom onset.³ Some earlier studies placed the peak closer to symptom onset or even slightly before.⁴ The difference likely reflects variant changes over time. Either way, you are at your most infectious during this window.
Days 5 through 7: Viral load is declining, but you’re still likely contagious. A Lancet study found that about two-thirds of patients still had culturable virus five days after symptom onset, and roughly a quarter still had it at day seven.⁵ This is the range where individual variation matters a lot.
Days 8 through 10: Most people have cleared live virus by now. By day ten, the probability of a sample containing replicable virus drops to around 6 percent, though that estimate carries wide uncertainty.⁶ An early study from England found a similar figure: just 6 percent chance of culturing virus from samples taken ten or more days after onset.⁷
Beyond day 10: For the vast majority of people, live virus is gone. PCR tests can stay positive for weeks, but that reflects dead viral fragments, not infectious particles. In a cohort study, virus growth and antigen tests were rarely positive beyond two weeks.⁸

For the Omicron variant specifically, a meta-analysis estimated the pooled duration of viable virus shedding at about five days, with PCR positivity lasting around eleven days.⁹ So the typical contagious window with Omicron is a bit shorter than with earlier strains, but the core pattern holds: peak early, decline over the first week, and gone for most people by ten days.

Your Symptoms Are a Poor Guide to Contagiousness

A common instinct is to judge your contagiousness by how you feel. If you still have a cough or fever, you assume you’re still spreading the virus; if you feel better, you assume you’re safe. The evidence doesn’t support this. A longitudinal cohort study of non-hospitalized adults found that the presence of fever, respiratory symptoms, and loss of taste or smell were not significantly associated with whether someone was still shedding live virus during the first two weeks after symptom onset.⁸ Some people feel terrible but have already cleared infectious virus. Others feel fine but are still shedding it.

The disconnect happens because many COVID-19 symptoms are driven by your immune response rather than by active viral replication. Inflammation, coughing, and fatigue can persist long after the virus itself has been neutralized. Conversely, pre-symptomatic and asymptomatic individuals can carry high viral loads while feeling perfectly healthy.

What Rapid Antigen Tests Actually Tell You

If symptoms aren’t reliable, what is? Rapid antigen tests turn out to be a surprisingly useful proxy for contagiousness. These tests detect viral proteins, and the amount of protein in your nose correlates reasonably well with whether live virus can be cultured from your sample. In that same cohort study, the presence of N antigen (the protein detected by most rapid tests) was strongly associated with culture positivity between days six and ten, with about a sevenfold higher chance of growing live virus when the antigen test was positive.⁸ PCR results, by contrast, were not associated with culture positivity during that same window.

This doesn’t mean rapid tests are perfect. Compared to same-day viral cultures, home antigen tests had a sensitivity of about 84 percent, meaning they missed about one in six people who were still shedding live virus.¹⁰ Lab-based antigen platforms performed somewhat better, with one microfluidic system reaching about 90 percent sensitivity for culture-positive samples.¹¹ The practical takeaway: a positive rapid test during your illness means you’re very likely still contagious. A negative rapid test is encouraging but not a guarantee, especially in the first day or two of illness when viral load may not have risen high enough to trigger the test yet.

Vaccination Shortens the Contagious Window

Vaccination doesn’t prevent infection, as we’ve all learned, but it does change the trajectory of viral shedding. Multiple studies have found that vaccinated people clear the virus faster than unvaccinated people, even when their initial viral loads are similar. In one study, fully vaccinated individuals had detectable live virus for about four days after symptom onset, compared to eight days for partially vaccinated and ten days for unvaccinated individuals.¹²

A separate analysis found a similar pattern: vaccinated people reached the same peak viral load as unvaccinated people and did so at about the same speed, but their clearance phase was substantially faster, averaging about 5.5 days compared to 7.5 days in unvaccinated individuals.¹³ The immune system of a vaccinated person recognizes the virus faster and ramps up its response more quickly, which truncates the back half of the viral shedding curve. This means the contagious window for a vaccinated person might run from a day before symptoms through roughly day five or six, versus a wider window extending toward day eight or ten for someone without prior immunity.

How Variants Changed the Timeline

The virus hasn’t stayed still, and neither has its contagious timeline. Each major variant has tweaked the speed of infection. Omicron subvariants reach peak viral load a bit sooner after exposure than Delta did. One study estimated that Delta viral trajectories peaked about 6.6 days after exposure, while BA.2 peaked at around 5.2 days.¹⁴ The generation interval, the average time between one person getting infected and infecting someone else, also shrank: roughly three days for Omicron compared to about four days for Delta.¹⁵

What this means practically is that the whole infection cycle has compressed. You get infected, become contagious, and hit peak infectiousness faster with Omicron than with earlier variants. The flip side is that the contagious period may also end slightly sooner for most people. But the pattern remains the same: a quick ramp-up, a peak in the first few days of illness, and a gradual decline over the following week.

Asymptomatic Infections Are Still Contagious

People who never develop symptoms remain a wild card. A systematic review and meta-analysis found no significant difference in viral load between symptomatic and asymptomatic COVID-19 patients based on PCR cycle-threshold values.¹⁶ An earlier study of asymptomatic patients did find somewhat lower viral loads in truly asymptomatic people compared to those who were tested before symptoms appeared but went on to develop them, though the duration of viral shedding was similar in both groups, hovering around seven to eight days.¹⁷

The upshot is that someone who never coughs, never gets a fever, and never feels unwell can still carry and shed enough virus to infect others. The contagious window for asymptomatic cases is harder to pin down precisely because there’s no “symptom onset” to anchor the timeline to, but the duration of shedding is broadly comparable to symptomatic cases. This is one reason why exposure-based isolation guidelines exist alongside symptom-based ones.

How You Actually Transmit the Virus During Peak Days

During the peak contagious window, the virus is shed primarily through respiratory aerosols, the tiny particles you exhale while breathing, talking, and singing. A study of hospitalized patients found that about 59 percent emitted detectable SARS-CoV-2 in their exhaled aerosols, and patients earlier in their illness (around day three) were more likely to emit detectable virus than those further along (around day five).¹⁸ Fine aerosols, the kind that hang in the air and can drift across a room, accounted for about 85 percent of the total viral RNA detected. Coarser droplets that fall quickly made up the remaining 15 percent.

There was also substantial person-to-person variation: some patients emitted thousands of viral gene copies per activity, while others emitted almost none. This variation helps explain why some infected people seem to spread the virus widely while others infect nobody at all, a pattern sometimes called overdispersion. Your peak contagious days are when aerosol shedding is highest, which aligns with the early symptomatic period described above.

When Immunocompromised People Remain Contagious Much Longer

The timelines described so far apply to people with reasonably functional immune systems. For immunocompromised individuals, the story can be dramatically different. Case reports have documented deeply immunocompromised patients shedding infectious virus for several months after symptom onset.¹⁹ In one series of three such patients, infectious virus was confirmed up to four months after symptoms began, with clinical courses that ranged from asymptomatic carriage to superinfection with a second strain.²⁰

This matters for people undergoing chemotherapy, organ transplant recipients on anti-rejection drugs, and those with severe immune deficiencies. Standard isolation timelines don’t apply in these cases. If you’re immunocompromised and test positive, your medical team will likely recommend serial testing rather than relying on a fixed number of days. The contagious window for this population needs to be determined individually.

Why PCR Can Stay Positive for Weeks After You’re No Longer a Risk

One of the most persistent sources of confusion has been the gap between PCR positivity and actual contagiousness. PCR tests are extraordinarily sensitive. They amplify tiny fragments of viral genetic material, and those fragments can persist in your respiratory tract long after the virus itself is dead. In one cohort, about half of participants tested between 21 and 30 days after symptom onset still had detectable viral RNA by PCR, even though virus growth in culture was rarely positive beyond two weeks.⁸

A large follow-up study from Wuhan underscored this point in striking fashion. Among over 20,000 patients discharged from the hospital, about 12 percent later tested positive again by PCR. But when researchers tracked over 4,000 close contacts of those re-positive patients, every single contact tested negative.²¹ The re-positive PCR results were picking up dead viral debris, not live virus capable of spreading. If you test positive by PCR three or four weeks into your illness and have been feeling better for a while, you’re almost certainly not a transmission risk.

Paxlovid Rebound and What It Means for Contagiousness

If you’ve taken Paxlovid (nirmatrelvir-ritonavir) and had your symptoms come roaring back a few days after finishing the five-day course, you’re experiencing what’s been called Paxlovid rebound. Modeling work has explored why this happens: the drug suppresses viral replication while you’re taking it, but if your own immune response hasn’t fully kicked in by the time the drug clears, the remaining virus can resume replicating.²² Viral loads during rebound can rise back above levels associated with infectiousness, and there have been documented cases of transmission during rebound episodes.

From a contagiousness standpoint, rebound effectively restarts the clock. You may have tested negative on day six or seven, only to test positive again on day nine or ten. If your rapid antigen test turns positive during rebound, treat yourself as contagious again. The rebound phase typically resolves within a few days, but it adds an unpredictable wrinkle to the timeline. For people considering Paxlovid, the tradeoff is still strongly favorable for those at high risk of severe illness, but the possibility of rebound means you might need to extend your period of caution by a few days beyond what you initially expected.

1
PubMed Central. Evidence for transmission of COVID-19 prior to symptom onset
2
PubMed Central. Latent and incubation periods of Delta, BA.1, and BA.2 variant cases and associated factors: a cross-sectional study in China
3
PubMed Central. The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs
4
Nature Reviews Microbiology. SARS-CoV-2 viral load and shedding kinetics
5
The Lancet Respiratory Medicine. Community transmission and viral kinetics of SARS-CoV-2 delta variant in vaccinated and unvaccinated individuals in the UK
6
PubMed Central. The duration of infectiousness of individuals infected with SARS-CoV-2
7
PubMed Central. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
8
PubMed Central. Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection
9
PubMed Central. Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis
10
PubMed Central. Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection
11
PubMed Central. Sars-Cov-2 antigen tests predict infectivity based on viral culture
12
JAMA Network Open. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
13
medRxiv. Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated individuals
14
PLOS Biology. Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants
15
PubMed Central. Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2
16
PubMed Central. Viral Load Difference between Symptomatic and Asymptomatic COVID-19 Patients: Systematic Review and Meta-Analysis
17
PubMed Central. Viral dynamics in asymptomatic patients with COVID-19
18
Oxford Academic. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing
19
PubMed Central. Long term SARS-CoV-2 infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection
20
The Journal of Infectious Diseases. Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection
21
BMC Medicine. A follow-up study shows that recovered patients with re-positive PCR test in Wuhan may not be infectious
22
PubMed Central. An explanation for SARS-CoV-2 rebound after Paxlovid treatment